Federation Des Caisses Desjardins Du Quebec Harrow Health, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 14, 2024
SELL
$13.84 - $21.46 $2,768 - $4,292
-200 Reduced 40.0%
300 $6.35 Million
Q1 2022

Aug 14, 2024
BUY
$6.77 - $8.66 $3,385 - $4,330
500 New
500 $3.41 Million
Q2 2021

Aug 30, 2024
BUY
$6.68 - $11.07 $3,340 - $5,535
500 New
500 $4.65 Million
Q1 2021

Aug 30, 2024
BUY
$6.26 - $11.03 $2,253 - $3,970
360 Added 72.0%
860 $5.81 Million
Q3 2019

Aug 30, 2024
BUY
$4.89 - $8.0 $2,445 - $4,000
500 New
500 $2.81 Million

Others Institutions Holding HROW

# of Institutions
176
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.06B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email